Interestingly, although XCR1 overexpression accentuated MDA-MB-231 cell migration, it was reported to suppress cell proliferation, tumorigenesis, and tumor growth, probably via the inhibition of MAPK activation with the reduced phosphorylation of MEK, JNK, and p38-MAPK [10]. The gene discussed is MAP2K7; the disease is neoplasm.